Ads
related to: msd manuals free download
Search results
Results From The WOW.Com Content Network
The Merck Manuals (outside the U.S. and Canada: The MSD Manuals; Chinese: 默沙东诊疗手册; pinyin: Mòshādōng Zhěnliáo Shǒucè) are medical references published by the American pharmaceutical company Merck & Co. (known as MSD outside the United States and Canada), that cover a wide range of medical topics, including disorders, tests, diagnoses, and drugs.
The first edition of The Merck Manual was published in 1899 by Merck & Co., Inc. for physicians and pharmacists and was titled Merck's Manual of the Materia Medica. [6] [7] The 192 page book which sold for US $1.00, was divided into three sections, Part I ("Materia Medica") was an alphabetical listing of all known compounds thought to be of therapeutic value with uses and doses; Part II ...
This is a list of mental disorders as defined in the DSM-IV, the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders.Published by the American Psychiatry Association (APA), it was released in May 1994, [1] superseding the DSM-III-R (1987).
The Merck Veterinary Manual is a reference manual of animal health care. It was first published by Merck & Co., Inc. in 1955. [1] It contains concise, thorough information on the diagnosis and treatment of disease in a wide variety of species. [2] The Manual is available as a book, published on a non-profit basis. [3]
Merck Manual of Diagnosis and Therapy, a medical textbook first published in 1899 by Merck & Co. Merck Index, a 1968 encyclopedia of chemistry, formerly published by Merck & Co. and now by the Royal Society of Chemistry; Merck Veterinary Manual, a reference manual of animal health care published by Merck & Co. and Merial Limited
Gardasil 9 in French packaging (showing the MSD branding) The company develops medicines, vaccines, biologic therapies and animal health products. In 2020, the company had 6 blockbuster drugs or products, each with over $1 billion in revenue: Keytruda (pembrolizumab), a humanized antibody used in cancer immunotherapy that had $14.3 billion in 2020 revenue; Januvia (sitagliptin), an anti ...